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Abstract
Objectives Differences in breast density between populations
may explain part of the variation in regional breast cancer
screening performance. This study aimed to determine wheth-
er regional differences in breast density distribution are pres-
ent in the Dutch screening population.
Methods As part of the DENSE trial, mammographic density
was measured using a fully-automated volumetric method.
The regions in our study were based on the geographic cov-
erage of 14 reading units representing a large part of the
Netherlands. General linear models were used.
Results Four hundred eighty-five thousand and twenty-one
screening participants with a median age of 60 years were
included (2013-2014). The proportion of women with hetero-
geneously or extremely dense breasts ranged from 32.5 % to
45.7 % between regions. Mean percent dense volume varied
between 6.51 % (95 % confidence interval [CI]: 6.46-6.55)
and 7.68 % (95 % CI: 7.66-7.71). Age differences could not
explain the variation. Socio-economic status (SES) was posi-
tively associated with volumetric density in all analyses (low
SES: 6.95 % vs. high SES: 7.63 %; ptrend<0.0001), whereas a
potential association between urbanisation and breast density
only became apparent after SES adjustment.
Conclusion There appears to be geographic variation in mam-
mographic density in the Netherlands, emphasizing the impor-
tance of including breast density as parameter in the evalua-
tion of screening performance.
Key Points
• Mammographic density may affect regional breast cancer
screening performance.
• Volumetric breast density varies across screening areas.
• SES is positively associated with breast density.
• Implications of volumetric breast density differences need to
be studied further.
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Urbanisation
Abbreviations
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VDG Volpara density grade
FFDM Full-field digital mammography
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MLO Mediolateral oblique
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%DV Percent dense volume
DV Dense volume
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Introduction
Mammographic interpretations are influenced by the dis-
tribution of fibroglandular and adipose tissue in the
breast. More fibroglandular tissue, i.e., a higher mam-
mographic density, is associated with both an increased
breast cancer risk and a decreased sensitivity of mammogra-
phy [1–3]. Due to the radiation attenuation characteristics of
this tissue, tumour masses could be masked on a mammogram
[1]. This results in a greater risk of breast carcinomas remain-
ing undetected.
Since breast density will affect breast cancer screening per-
formance, it is important to be aware of differences in mam-
mographic density distribution between the coverage areas of
screening radiology groups. Previous screening evaluation
studies revealed differences in breast cancer detection rates
across the Netherlands [4, 5]. The extent to which variation
in breast density has contributed to these differences has not
yet been determined. The average radiologist reads 13,000
mammograms per year, but breast density is not taken into
account in the evaluation of this high-volume reading.
Objective density measurements are needed for a definitive
answer on the magnitude of the geographic differences and
the resulting effect on screening performance. Furthermore,
the geographic distribution of breast density may provide
more insight into differential breast cancer risk.
The Dutch breast cancer-screening programme started in
1989. Until now, geographic comparisons of mammographic
density were not possible due to the lack of structural breast
density assessments. As part of the DENSE trial, the volumet-
ric breast density distribution could be determined using un-
processed mammogram data collected from screening units
throughout the country [6]. Although this is, to our knowl-
edge, the first study to address the geographic variation in
volumetric breast density within a national screening pro-
gramme, a few studies have reported on the association of
geographic (e.g., urbanisation level) and demographic (e.g.,
socio-economic status [SES]) characteristics with breast den-
sity [7–11]. These factors may help clarify differences be-
tween screening areas, but the previous results have been
somewhat inconsistent. A positive association of breast den-
sity with SES [7, 9, 11] and urbanisation [8, 10] has been
suggested, although disagreement exists on the strength of
the associations.
With this study, we want to contribute to the discus-
sion on measuring breast density in national screening
programmes. Breast density should only be included as
a parameter in a screening evaluation if there is evidence of
geographic differences in breast density. The aim of this study
was, therefore, to determine whether regional differences in
volumetric breast density are present in the Netherlands. In
addition, we studied the association of breast density with
SES and urbanisation.
Methods
Study population and data collection
Women aged 50-75 years are invited biennially for breast
cancer screening in the Netherlands. They receive their first
invitation in the year they turn 50 or 51 years old. This pro-
gramme has a full national coverage, with relatively high at-
tendance (79.6 % in 2012) compared to other European
programmes [5, 12]. Phased installation of density software
on servers in screening units of the Dutch programme started
in January 2013. Examinations performed at these units be-
tween implementation and February 2014 were included in
our study. In the Netherlands, screening examinations are read
by different radiology groups (hereinafter referred to as read-
ing units) across the country. Mammographic data are central-
ly stored in a national database and, depending on the screen-
ing unit location (ntotal=77; 57 mobile, 22 fixed), distributed
to specific reading units. The 14 reading units in our study (out
of 16 nationwide), therefore, all have different coverage areas,
with minimal overlap. Together, they cover a substantial part
of the most densely populated areas of the Netherlands, with
four out of five screening regions participating in this study.
To improve readability of the results, the reading units were
numbered, but this does not match the previously used coding
in the literature [4, 5]. The name of each reading unit (based on
its location) is described below Table 3, with the correspond-
ing Dutch provinces they (partly) cover in brackets.
As part of the DENSE trial, breast density profiles of par-
ticipants at enrolled screening units were estimated using un-
processed digital mammogram data. The DENSE trial
(NCT01315015) has been described elsewhere [6]. In short,
DENSE investigates the (cost-) effectiveness of screening
with mammography and MRI, compared to mammography
alone in Dutch breast cancer screening participants with ex-
tremely dense breasts (BI-RADS density 4/d).
Data on age at screening and four-digit postal codes were
obtained for all those being screened. Screening participants
are informed about the potential use of screening data in re-
search aimed to improve the programme. Based on Dutch law,
medical ethics approval was not needed because anonymized
data were used for this study.
SES and urbanisation
The Netherlands Institute for Social Research (Sociaal en
Cultureel Planbureau; SCP) has provided a measure of SES,
which combines educational level, income, and labour market
position [13]. The SCP collected information on SES by
interviewing one person in every six-digit postal code area
between 2006 and 2010. This information was then combined
to give one score for every four-digit postal code area. The
scores were linked to the postal codes in our dataset.
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Degree of urbanisation is based on the number of addresses
per square kilometre. Statistics Netherlands has published a
five-level categorical scale, with less than 500 addresses at the
lowest and more than 2500 addresses at the highest urbanisa-
tion level [14, 15]. The urbanisation degree can be retrieved
for each neighbourhood in the Netherlands. The postal codes
of these neighbourhoods were matched to the postal codes of
the participants.
Mammographic density
Since the nationwide implementation of full-field digital mam-
mography (FFDM) was completed in 2010, all screening ex-
aminations in our study were performed digitally using Selenia
systems (Hologic, Bedford, USA). Breast density was deter-
mined using Volpara Imaging Software (version 1.5)
(Mātakina, Wellington, New Zealand). This FDA-approved
software calculates total breast volume (in cm3), fibroglandular
tissue volume (dense volume [DV]; in cm3), fat tissue volume
(non-dense volume; in cm3), and percentage fibroglandular tis-
sue (percent dense volume [%DV]) based on the measured X-
ray attenuation per pixel [16, 17]. Volpara has developed a
categorical scale as an approximation of the BI-RADS density
scale: the Volpara Density Grade (VDG). The %DV is divided
into four categories on the VDG-scale (with in brackets the
corresponding BI-RADS density): VDG1=<4.5 % (almost en-
tirely fatty), VDG2=4.5-7.5 % (scattered areas of density),
VDG3=7.5-15.5 % (heterogeneously dense), and VDG4=>
15.5 % (extremely dense) [18, 19]. The VDG is based on the
mean %DVof all views.
The Volpara software version used in the DENSE trial only
gives an estimate when both the mediolateral oblique (MLO)
and craniocaudal (CC) view are available. The resulting esti-
mate is the average of both. Since a recent policy change
(decision made in 2013, officially implemented in 2014),
two-viewmammography is standard and both views are avail-
able for all examinations in the current programme [20].
Directly prior to the policy change, two-view mammography
was already widely applied, including in women participating
for the first time. Both views were obtained in 99 % of the
examinations in the regions included in our study.
In addition, since the difference in density between the left
and right view is known to be small, the average of these
estimates was used [21]. In this study, the Pearson correlation
coefficient for the left and the right view was 0.95, 0.91, 0.98,
and 0.98 for %DV, DV, non-dense volume, and total breast
volume, respectively.
Statistical analyses
A natural logarithmic transformation [ln(x+1)] was applied to
%DV and DV. General linear models were used to calculate
geometric means and corresponding 95 % confidence intervals
(CI) of %DVand DV per reading unit. Furthermore, means of
the densitymeasures were calculated for every SES quartile and
every urbanisation level. Linear trends were studied with poly-
nomial contrasts. Log-binomial regression was used to study
the effect of SES and urbanisation on the VDG. For this anal-
ysis, the VDGwas dichotomized into VDG1+2 and VDG3+4.
In addition to our main analyses, we performed secondary
analyses with two important confounders to provide some
insight into the causal association between geographic area
and breast density. The first potential confounder included in
our models was age at screening. Although the invitation age
range is the same in all regions, the age distribution may have
varied. Furthermore, dense volume was adjusted for total
breast volume. Total breast volume can be seen as a proxy
for body-mass index (BMI).
All values were transformed back to the original scale in
the tables for ease of interpretation. The statistical tests were
two-sided, with a significance level of 0.05. All analyses were
performed using SAS software (version 9.2, SAS Institute).
Results
A total of 485,021 screening participants were included in our
analyses (Table 1). The median age at screening was 60 years
(IQR 54-66 years). All density measures are shown in Table 2.
Table 1 Baseline characteristics of the study population (n=485,021)
Variables
Median (IQR)
Age (in years) 60 (54-66)
% (N)
Screening region
Mid-west 37.0 (179,261)
East 16.9 (81,962)
South 21.5 (104,198)
South-west 24.7 (119,600)
SES
Q1 (lowest SES) 25.1 (121,590)
Q2 24.7 (119,810)
Q3 25.1 (121,923)
Q4 (highest SES) 24.9 (120,704)
Missing 0.2 (994)
Urbanisation level (addresses/km2)
Very high (≥2500) 23.2 (112,333)
High (1500-2499) 31.1 (150,813)
Moderate (1000-1499) 18.3 (88,578)
Low (500-999) 16.7 (81,185)
Very low (0-499) 10.7 (52,112)
IQR = inter-quartile range, SES = socio-economic status
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The geometric means of %DV and DV were 7.25 % and
56.97 cm3, respectively. The confidence intervals were similar
to the mean estimates due to the large sample size. There were
196,312 women (40.5 %) who could be classified as having
heterogeneously (VDG3) or extremely (VDG4) dense breasts,
with 38,330 women (7.9 %) in the latter category. Age was
inversely associated with %DVand DV (ptrend<0.0001). The
proportion of women with a VDG3/VDG4 classification de-
creased from 60.7 % in the youngest to 28.1 % in the oldest
age group. Total breast volume increased with age (ptrend<
0.0001) up until 65-70 years, after which it slightly decreased.
Geographic variation
Table 3 and Fig. 1 show the geographic variation in breast
density in the Netherlands. In the first region (reading unit 1),
32.5 % of the women had heterogeneously (VDG3) or ex-
tremely (VDG4) dense breasts. The proportion of women with
VDG3/VDG4 in the coverage area of reading unit 14 was
45.7 %. The mean %DV ranged from 6.51 % (95 % CI: 6.46-
6.55 %) in the coverage area of reading unit 1 to 7.68 % (95 %
CI: 7.66-7.71 %) in the coverage area of reading unit 14. DV
ranged from 53.93 cm3 (unit 3; 95 % CI: 53.47-54.40 cm3) to
59.36 cm3 (unit 6; 95 % CI: 59.08-59.65 cm3). The geographic
variation in mammographic density could not be explained by
age differences. Although adjustments for total breast volume
did have an effect on DV in some regions, geographic variation
in DV still appeared to be present in the fully adjusted model
(including age and total breast volume).
Association with SES
The %DV is higher among women with higher SES (mean
%DV Q1=6.95 % vs. Q4=7.63 %; ptrend<0.0001) (Table 4).
Adjustments for age or urbanisation had little effect on these
associations. The positive association between SES and DV
only became apparent after adjustment for total breast volume
(Table 4). A high SES was also associated with a high VDG
(age-adjusted RR Q4 vs. Q1=1.20, 95 % CI: 1.19-1.21)
(Table 5).
Association with urbanisation
There was minimal evidence of a linear association be-
tween urbanisation level and the various density measures
(crude mean %DV rural=7.19 % vs. high urbanisation=
7.27 %; ptrend=0.0052) (Table 4). The significant ptrend
appeared to be mainly driven by the large numbers and
the higher density at the highest urbanisation level, espe-
cially in the analyses on DV, whereas the density values
appeared to be similar for all other urbanisation levels.
When the estimates were additionally adjusted for SES,
the positive association between breast density and urban-
isation became more pronounced. Similar effects were ob-
served in the analyses with VDG (Table 5). This suggests a
confounding role of SES, which was confirmed by the
presence of an inverse association between urbanisation
level and SES (data not shown).
Discussion
Our results show that there is geographic variation in volumet-
ric breast density in the Netherlands. Breast density, measured
as %DV or DV, varies across the coverage areas of different
reading units in the Dutch screening programme. Differences
in breast density were also observed for different SES groups,
with higher SES being associated to higher breast density. A
Table 2 Different breast density measures according to age
N Geometric mean (95 % CI) % (N)
%DV (%) DV (cm3) Total volume (cm3) VDG3+4 VDG 4
Total 485,021 7.25 (7.25-7.25) 56.97 (56.97-56.97) 860.9 (859.8-862.1) 40.5 (196,312) 7.9 (38,330)
Age group
<50 ya 13,446 9.27 (9.20-9.35) 67.33 (66.81-67.86) 799.3 (792.0-806.6) 60.7 (8156) 19.4 (2606)
50-55 y 116,188 8.33 (8.31-8.35) 62.10 (61.94-62.27) 819.9 (817.4-822.4) 52.6 (61,121) 13.9 (16,119)
55-60 y 105,345 7.23 (7.21-7.25) 56.22 (56.06-56.38) 850.6 (847.9-853.3) 41.3 (43,549) 7.5 (7875)
60-65 y 96,437 6.83 (6.81-6.85) 55.29 (55.13-55.45) 879.4 (876.5-882.2) 36.2 (34,912) 5.6 (5407)
65-70 y 88,258 6.61 (6.59-6.63) 55.21 (55.05-55.38) 902.3 (899.3-905.4) 32.7 (28,830) 4.4 (3922)
70-75 y 59,405 6.47 (6.44-6.49) 53.15 (52.95-53.35) 883.7 (880.0-887.3) 30.4 (18,047) 3.7 (2200)
75 y+ 5942 6.34 (6.26-6.42) 52.22 (51.61-52.83) 883.2 (871.7-894.7) 28.1 (1670) 3.4 (201)
ptrend <0.0001 <0.0001 <0.0001
%DV = percent dense volume, DV = dense volume, CI = confidence interval, VDG = volpara density grade
a The time of first invitation is based on location and birth year. Women receive their first invitation in the year they turn 50 or 51 years of age. As a result,
a number of women were still 49-years-old at first screening (n=13,408) and even a few 48-year-olds were included (n=38)
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potential positive association with urbanisation level only be-
came apparent after SES adjustments. Differences in age did
not explain the observed associations.
In the interpretation of these results, one should take into
account that volumetric breast density estimates tend to be
lower than estimates obtained with area-based methods (e.g.,
Cumulus). Consequently, the differences in volumetric densi-
ty will also tend to be smaller. The observed variation in den-
sity may, thus, be associated with a greater difference in breast
cancer risk or screening performance than one may intuitively
expect based on previous studies involving Cumulus’ percent
density.
Based on studies with screen-film mammography (SFM),
screening performance (e.g., sensitivity and recall rates) can
be affected by breast density [22–26]. Preliminary evidence
has suggested that FFDM performs better in dense breasts
than SFM [27, 28]. Evidence on sensitivity across density
categories in FFDM, however, is scarce. Two studies in the
US, with annual instead of biennial screening, observed no
clear pattern in their secondary analyses on sensitivity within
different density categories [29, 30]. However, as mentioned
by Kerlikowske et al., missing measurements resulted in
limited statistical power and may have introduced bias [29].
In addition, the greater proportion of BI-RADS 0 classifica-
tions with FFDM compared with SFM could be associated
with high density. Additional imaging in this group may have
resulted in a higher screen-detected cancer rate. Finally, adjust-
ments for facility and radiologist effects appeared to reverse the
findings. More studies are, thus, still needed on the effect of
breast density on FFDM performance in the Netherlands.
Using parameters from SFM studies, however, we can es-
timate the expected variation in screening performance of the
reading units due to differences in breast density distribution.
With the performance parameters stratified on BI-RADS den-
sity of Yankaskas et al., for example, we can calculate weight-
ed averages (weighted on VDG distributions) to estimate per-
formance (e.g., sensitivity) in each reading unit in our study
[26]. Using these parameters, a small amount of the perfor-
mance variation could be explained by breast density differ-
ences in our population, with sensitivity ranging between
76.9-80.3 % across reading units (range recall rate: 53.9-
59.7 per 1000; range cancer detection: 3.28-3.34 per 1000).
Overall estimates of screening performance in the US are,
however, very different from the overall Dutch estimates (in
Mean volumetric breast density (%)
6.5 - 6.9
6.9 - 7.1
7.1 - 7.5
7.5 - 8.0                           
No data
Fig. 1 Age-adjusted geometric
means of the percent dense
volume across the Netherlands
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2011: recall=21.4 per 1000; cancer detection=6.2 per 1000)
[5]. The effect of density on screening performance in the
Netherlands, thus, still needs to be assessed.
Breast density is also associated with breast cancer risk
[1, 3, 31]. Indeed, a similar gradient in breast cancer incidence
appeared to exist across the country [32]. Since we focused on
the effect of density on screening practice, no information on
other risk factors was collected. Differential screening atten-
dance may have contributed to the variation in volumetric
breast density. Both SES and urbanisation are factors that
could be associated with attendance. When we included these
factors in the regional analyses, the observed variation in vol-
umetric breast density slightly decreased (data not shown).
The remaining differences would have to be attributed to un-
measured or even unknown confounders. Aetiological infer-
ences on differences in %DV are hindered by the absence of
information on BMI. Because DV is expected to be less af-
fected by BMI confounding, based on a meta-analysis involv-
ing dense area [33], the observed differences in DV do indi-
cate that variation in dense tissue is present that may translate
into a difference in breast cancer risk. Further studies are
needed to confirm this result.
A study on four widely dispersed geographic areas showed
that differences in breast density could be explained by well-
known confounders, including reproductive behaviour [34].
Other studies on breast density have corrected for use of hor-
mone replacement therapy (HRT). Only 13 % of Dutch wom-
en (49-70 years) used HRT in the 1990s [35], and the percent-
age is expected to be even lower since the publication of the
Million Women Study on the adverse effects of HRT [36].
Based on the low HRT-use, this risk factor is not expected to
have had a significant effect here.
To get more insight into the geographic differences, we
further studied SES and urbanisation. A (weak) positive asso-
ciation between SES and breast density has been observed
before [7, 9, 11]. Despite the differences in setting (e.g., coun-
try) and definitions (both SES and density), these results ap-
pear to be consistent with our observations. Potential explan-
atory factors include differences in BMI and reproductive be-
haviour. If a high BMI is associated with a low %DV and a
low SES, then the differences in %DV between SES groups
could be explained by variation in BMI. In contrast, based on
the positive correlation between BMI and DV observed in
previous studies, BMI adjustment is only expected to increase
variation in DV [37, 38]. This was supported by the results
from our models including total breast volume (a BMI-proxy).
A linear association between urbanisation and breast den-
sity became apparent after SES adjustment. In general, the
results were somewhat suggestive of an increased density at
the highest urbanisation level. Two previous studies involving
urbanisation and BI-RADS density found a positive associa-
tion [8, 10]. Both authors described a potential link with ex-
posure to environmental factors. Aitken et al., on the other
hand, did not observe an association between a dichotomous
rural/urban measure and breast density [7].
One of the limitations of our study is that we usedmeasures
at area level (i.e., postal codes) instead of individual level (like
educational level) for both urbanisation and SES, which may
have led tomisclassification. However, we expect the misclas-
sification to be independent of outcome (high/low volumetric
Table 5 Volpara Density Grade for levels of SES or urbanisation
% (N) RRa (95 % CI)
VDG3+4 VDG4 Crude Adjustedc Adjustedd
SESb
Q1 (lowest SES) 37.0 (45,033) 6.9 (8377) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)
Q2 39.1 (46,864) 7.3 (8720) 1.06 (1.05-1.07) 1.06 (1.05-1.07) 1.07 (1.06-1.08)
Q3 40.5 (49,419) 7.9 (9592) 1.09 (1.08-1.11) 1.09 (1.08-1.10) 1.11 (1.10-1.12)
Q4 (highest SES) 45.2 (54,563) 9.6 (11,555) 1.22 (1.21-1.23) 1.20 (1.19-1.21) 1.22 (1.21-1.23)
Urbanisation
Very high 40.7 (45,703) 8.4 (9469) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)
High 39.9 (60,227) 7.6 (11,467) 0.98 (0.97-0.99) 0.98 (0.97-0.99) 0.97 (0.96-0.98)
Moderately high 41.2 (36,530) 7.9 (7034) 1.01 (1.00-1.02) 1.01 (1.00-1.02) 0.96 (0.95-0.97)
Low 40.4 (32,834) 7.8 (6367) 0.99 (0.98-1.01) 1.00 (0.99-1.01) 0.96 (0.95-0.97)
Very low 40.3 (21,018) 7.7 (3993) 0.99 (0.98-1.00) 0.99 (0.98-1.01) 0.95 (0.93-0.96)
SES = socio-economic status, RR = risk ratio, CI = confidence interval, VDG = volpara density grade,
a These RRs were estimated using log-binomial regression: VDG3+4 compared to VDG1+2
b The 994 women for whom SES status had not been identified were excluded from the analyses on SES
cAdjusted for age
dAdjusted for age and urbanisation level (in the SES analyses) or SES (in the urbanisation analyses)
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density). Although the suggestion that this can only lead to
attenuation of the true effect does not always hold [39], we deem
it unlikely that the observed effect can be explained entirely by
misclassification. An analysis with SES as a continuous variable
appeared to confirm the positive trend (data not shown).
Furthermore, previous studies have shown that area-based mea-
sures give a good approximation of individual SES [40].
Another limitation is the fact that the CC views tend to be
missing more often for women with fatty breasts and these
lower density values were, thus, not included in our dataset,
although the overall number of missing CCs was small (1 %).
When we limited the analyses to a period with 100 % available
CC views, the three reading units with the highest density
remained at the top and the overall differencewith the low breast
density units was similar. Small differences can be explained by
slight fluctuations in the invited populations over time.
Strengths include the automated volumetric density mea-
surements. The lack of intra- or interobserver variability en-
ables comparison of different reading units. Studies using
qualitative measures would be affected by differences in den-
sity assessment behaviour of radiologists [41]. In addition,
there is limited variation in technology, methodology, and
training in the Dutch screening programme, which could oth-
erwise have confounded the results. Finally, the large study
population is expected to be representative of the Dutch
screened population, as women from all SES classes have
access to high-quality screening.
In conclusion, differences in breast density between re-
gions in the Netherlands have been established in this study.
Geographic variation in breast density is likely to be present in
other countries as well. Due to limited evidence on the asso-
ciation between volumetric density and screening perfor-
mance, the clinical implications of these differences remain
to be further elucidated. This will help move the discussion
on routine breast density measurements in screening forward.
Provided that there is an adequate infrastructure regarding the
storage of unprocessed mammogram data, automated soft-
ware programs could potentially be used to obtain reproduc-
ible breast density measurements within national screening
programmes.
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